Severe adverse drug reaction to gadobenate dimeglumine

TheScientificWorldJournal

Volumn 9, Issue , 2009, Pages 363-365

  Singer, Benjamin D ^a   Woodrick, Robert S ^a   Pedicano, Jennifer B ^b  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^b NONE

Author keywords

Anaphylactoid reaction; Anaphylaxis; Gadobenate dimeglumine; Gadolinium

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ALLOPURINOL; ATROPINE; DIPHENHYDRAMINE; DOPAMINE; FAMOTIDINE; FLUTICASONE; GADOBENATE DIMEGLUMINE; GADOLINIUM; GADOLINIUM PENTETATE MEGLUMINE; HEPARIN; IODINATED CONTRAST MEDIUM; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; METHYLPREDNISOLONE; NORADRENALIN; PHENYLEPHRINE; SERTRALINE; TERAZOSIN; VASOPRESSIN; CONTRAST MEDIUM; DRUG DERIVATIVE; GADOBENIC ACID; MEGLUMINE; ORGANOMETALLIC COMPOUND;

ABSENCE OF SIDE EFFECTS; ADULT; ALLERGIC RHINITIS; ANAMNESIS; ANAPHYLACTIC SHOCK; ARTICLE; CASE REPORT; CONTRAST ENHANCEMENT; DEEP VEIN THROMBOSIS; DEPRESSION; DISEASE COURSE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DYSPNEA; ERYTHEMA; GOUT; HEART ARREST; HEART ATRIUM SEPTUM DEFECT; HUMAN; HYPOTENSION; HYPOXEMIA; LIP SWELLING; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHLEBOGRAPHY; PROSTATE HYPERTROPHY; RESUSCITATION; STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME; URTICARIA; ANAPHYLAXIS; CHEMICALLY INDUCED DISORDER; METHODOLOGY; MIDDLE AGED; PELVIS; VASCULARIZATION;

ANAPHYLAXIS; CONTRAST MEDIA; HEART ARREST; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PELVIS; PHLEBOGRAPHY;

EID: 66849138011     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2009.41     Document Type: Article

References (13)

1. Cochran, S.T. (2005) Anaphylactoid reactions to radiocontrast media. Curr. Allergy Asthma Rep. 5, 28.
2. Committee on Drugs and Contrast Media (1998) Adverse Reactions to Gadolinium-Based Contrast Media. Manual on Contrast Media. American College of Radiology, Reston, VA.
3. Li, A., Wong, C.S., Wong, M.K., Lee, C.M., and Au Yeung, M.C. (2006) Acute adverse reactions to magnetic resonance contrast media - gadolinium chelates. Br. J. Radiol. 79, 368.
4. Dillman, J.R., Ellis, J.H., Cohan, R.H., Strouse, P.J., and Jan, S.C. (2007) Frequency and severity of acute allergiclike reactions to gadolinium-containing IV contrast media in children and adults. Am. J. Roentgenol. 189, 1533.
5. MultiHance; MSDS; Bracco Diagnostics Inc: Princeton, NJ, November 29, 2004. http://usa.braccoimaging.com/images/stories/pdf/mri/multihance/ MultiHanceMSDSNov2004.pdf (accessed May 13, 2009).
6. Shellock, F., Parker, J., Venetianer, C., Pirovano, G., and Spinazzi, A. (2006) Safety of gadobenate (Multihance): summary of findings from clinical studies and postmarketing surveillance. Invest. Radiol. 41, 500.
7. Joffe, P., Thomsen, H.S., and Meusel, M. (1998) Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis. Acad. Radiol. 5, 491. (Pubitemid 28303906)
8. Kalogeromitros, D.C., Makris, M.P., Aggelides, X.S., et al. (2007) Anaphylaxis to gadobenate dimeglumine (Multihance): a case report. Int. Arch. Allergy Immunol. 144, 150.
9. Tardy, B., Guy, C., Barral, G., Page, Y., Ollagnier, M., and Bertrand, J.C. (1992) Anaphylactic shock induced by intravenous gadopentetate dimeglumine. Lancet 339, 494.
10. Weiss, K.L. (1990) Severe anaphylactoid reaction after IV Gd-DTPA. Magn. Reson. Imaging 8, 817.
11. Rahman, S.L., Harbinson, M.T., Mohiaddin, R., and Pennell, D.J. (2005) Acute allergic reaction upon first exposure to gadolinium-DTPA: a case report. J. Cardiovasc. Magn. Reson. 7, 849. (Pubitemid 41770066)
12. Meuli, R.A. and Maeder, P. (1996) Life-threatening anaphylactoid reaction after IV injection of gadoterate meglumine. Am. J. Roentgenol. 166, 729.
13. Hasdenteufel, F., Luyasu, S., Renaudin, J.M., et al. (2008) Anaphylactic shock after first exposure to gadoterate meglumine: two case reports documented by positive allergy assessment. J. Allergy Clin. Immunol. 121, 527. (Pubitemid 351215162)